Ajooni Biotech Limited (IN:AJOONI)
:AJOONI
Want to see IN:AJOONI full AI Analyst Report?
Total Valuation
Ajooni Biotech Limited has a market cap or net worth of ―. The enterprise value is ₹833.42M.
Market Cap―
Enterprise Value₹833.42M
Share Statistics
Ajooni Biotech Limited has 172,243,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding172,243,590
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajooni Biotech Limited’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.15%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)2.15%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee10.52M
Profits Per Employee297.06K
Employee Count109
Asset Turnover1.21
Inventory Turnover4.21
Valuation Ratios
The current PE Ratio of Ajooni Biotech Limited is 11.3. Ajooni Biotech Limited’s PEG ratio is -1.89.
PE Ratio11.3
PS Ratio0.97
PB Ratio1.26
Price to Fair Value1.26
Price to FCF-5.78
Price to Operating Cash Flow5.38
PEG Ratio-1.89
Income Statement
In the last 12 months, Ajooni Biotech Limited had revenue of 1.15B and earned 32.38M in profits. Earnings per share was 0.18.
Revenue1.15B
Gross Profit138.13M
Operating Income25.95M
Pretax Income43.29M
Net Income32.38M
EBITDA57.57M
Earnings Per Share (EPS)0.18
Cash Flow
In the last 12 months, operating cash flow was 135.46M and capital expenditures -117.15M, giving a free cash flow of 18.31M billion.
Operating Cash Flow135.46M
Free Cash Flow18.31M
Free Cash Flow per Share0.11
Dividends & Yields
Ajooni Biotech Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-29.29%
50-Day Moving Average4.44
200-Day Moving Average4.88
Relative Strength Index (RSI)50.95
Average Volume (3m)354.25K
Important Dates
Ajooni Biotech Limited upcoming earnings date is May 11, 2026, Before Open (Confirmed).
Last Earnings DateJan 30, 2026
Next Earnings DateMay 11, 2026
Ex-Dividend Date―
Financial Position
Ajooni Biotech Limited as a current ratio of 12.86, with Debt / Equity ratio of 11.32%
Current Ratio12.86
Quick Ratio7.89
Debt to Market Cap0.02
Net Debt to EBITDA-0.85
Interest Coverage Ratio7.76
Taxes
In the past 12 months, Ajooni Biotech Limited has paid 10.91M in taxes.
Income Tax10.91M
Effective Tax Rate0.25
Enterprise Valuation
Ajooni Biotech Limited EV to EBITDA ratio is 18.43, with an EV/FCF ratio of -5.52.
EV to Sales0.93
EV to EBITDA18.43
EV to Free Cash Flow-5.52
EV to Operating Cash Flow-6.17
Balance Sheet
Ajooni Biotech Limited has ₹152.87M in cash and marketable securities with ₹88.71M in debt, giving a net cash position of ₹64.16M billion.
Cash & Marketable Securities₹152.87M
Total Debt₹88.71M
Net Cash₹64.16M
Net Cash Per Share₹0.37
Tangible Book Value Per Share₹4.80
Margins
Gross margin is 16.70%, with operating margin of 2.26%, and net profit margin of 2.82%.
Gross Margin16.70%
Operating Margin2.26%
Pretax Margin3.77%
Net Profit Margin2.82%
EBITDA Margin5.02%
EBIT Margin4.07%
Analyst Forecast
The average price target for Ajooni Biotech Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast43.84%
EPS Growth Forecast35.06%